Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Spotlight on P2Y2 agonists: a new target for cystic fibrosis

May 6, 1998

Surfaxin as ARDS treatment enters phase II/III

May 5, 1998

Nebulized furosemide beneficial in patients with acute asthma of short-term duration

May 4, 1998

AxyS Pharmaceuticals' APC-366 shows good antiasthmatic activity in phase IIa trial

May 1, 1998

New PDE IV inhibitors for asthma reported by Celltech

April 30, 1998

Astra obtains rights from Takeda to develop TxA2 antagonist

April 30, 1998

U.K. market introduction for long-acting, nonsedating antihistamine

April 29, 1998

Sepracor completes norastemizole trial; additional studies planned

April 29, 1998

Glaxo Wellcome launches Flovent for pediatric asthma in U.S.

April 28, 1998

Glaxo Wellcome seeks approval for combination asthma product

April 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...